Mechanisms mediating oxalate-induced alterations in renal cell functions

Critical Reviews in Eukaryotic Gene Expression

Volumn 13, Issue 1, 2003, Pages 55-72

  Jonassen, Julie A ^a   Cao, Lu Cheng ^a   Honeyman, Thomas ^a   Scheid, Cheryl R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Extracellular matrix; Gene expression; Kidney stone; Mitochondria; Osteopontin; Oxalate; Reactive oxygen species

Indexed keywords

ARACHIDONIC ACID; CALCIUM OXALATE; CERAMIDE; CHEMOKINE; CYTOCHROME C; LYSOPHOSPHOLIPID; OSTEOPONTIN; REACTIVE OXYGEN METABOLITE; SCLEROPROTEIN;

ANIMAL CELL; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CRYSTALLIZATION; ENZYME MECHANISM; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; IMMEDIATE EARLY GENE; KIDNEY CELL; MITOCHONDRIAL RESPIRATION; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STONE FORMATION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CALCIUM OXALATE; GENE EXPRESSION; HUMANS; KIDNEY CALCULI; LIPID METABOLISM; MITOCHONDRIA; MODELS, BIOLOGICAL; OSTEOPONTIN; OXALATES; REACTIVE OXYGEN SPECIES; SIALOGLYCOPROTEINS;

ANIMALIA;

EID: 0038266222     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukaryotGeneExpr.v13.i1.50     Document Type: Review

References (130)

1. Adhirai M, Selvam R (1997): Effect of cyclosporin A on tissue lipid peroxidation and membrane bound phosphatases in hyperoxaluric rat and the protection by vitamin E pretreatment. Jpn J Med Sci Biol 50:9-17.
2. Antus B, Exton MS, Rosivall L (2001): Angiotensin II: a regulator of inflammation during renal disease? Int J Immunopathol Pharmacol 14:25-30.
3. Aronson PS (1996): Role of ion exchangers in mediating NaCl transport in the proximal tubule. Kidney Int 49:1665-1670.
4. Atmani F, Glenton PA, Khan SR (1999): Role of inter-alpha-inhibitor and its related proteins in experimentally induced calcium oxalate urolithiasis. Localization of proteins and expression of bikunin gene in the rat kidney. Urol Res 27:63-67.
5. Baggio B (1999) Genetic and dietary factors in idiopathic calcium nephrolithiasis. What do we have, what do we need? J Nephrol 12:371-374.
6. Baggio B, Gambaro G (1999): Abnormal arachidonic acid content of membrane phospholipids-the unifying hypothesis for the genesis of hypercalciuria and hyperoxaluria in idiopathic calcium nephrolithiasis. Nephrol Dial Transplant 1:553-555.
7. Baggio B, Budakovic A, Nassuato MA, Vezzoli G, Manzato E, Luisetto G, Zaninotto M (2000): Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int 58: 1278-1284.
8. Bigelow MW, Wiessner JH, Kleinman JG, Mandel NS (1997): Surface exposure of phosphatidylserine increases calcium oxalate crystal attachment to IMCD cells. Am J Physiol 272:F55-F62.
9. Bradshaw AD, Sage EH (2001): SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107:1049-1054.
10. Bushinsky DA, Asplin JR, Grynpas MD, Evan AP, Parker WR, Alexander KM, Coe FL (2002): Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 61(3):975-987.
11. Bushinsky DA (2003): Nephrolithiasis: site of the initial solid phase. J Clin Invest 111:602-605.
12. Cao LC, Honeyman T, Jonassen J, Scheid C (2000): Oxalate-induced ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cells. Kidney Int 57: 2403-2411.
13. Cao LC, Honeyman TW, Scheid CR (2001a): Role of mitochondria in oxalate actions on renal cells. In Kok DJ, Romijn HC, Verhagen CMS, Verkoelen CF (eds): "Eurolithiasis." 9th Eur Symp of Urolithiasis, Maastricht, the Netherlands: Shaker Publishing, 110-111.
14. Cao LC, Jonassen J, Honeyman TW, Scheid C (2001b): Oxalate-induced redistribution of phosphatidylserine in renal epithelial cells. Implications for kidney stone disease. Am J Nephrol 21:69-71.
15. Cao Z, Cooper ME. (2001): Role of angiotensin II in tubulointerstitial injury. Semin Nephrol 21:554-562.
16. Chatterjee S (1993): Neutral sphingomyelinase. Adv Lipid Res 26:25-48.
17. Chen Y, Morimoto S, Kitano S, Koh E, Fukuo K, Jiang B, Chen S, Yasuda O, Hirotani A, Ogihara T (1995): Lysophosphatidylcholine causes Ca2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells. Atherosclerosis 112:69-76.
18. Chikama S, Iida S, Inoue M, Kawagoe N, Tomiyasu K, Matsuoka K, Noda S, Takazono I (2002): Role of heparan sulfate proteoglycan (syndecan-1) on the renal epithelial cells during calcium oxalate monohydrate crystal attachment. Kurume Med J 49:201-210.
19. Crompton M (1999): The mitochondrial permeability transition pore and its role in cell death. Biochem J 341: 233-249.
20. Danpure CJ (2000): Genetic disorders and urolithiasis. Urol Clin North Am 27:287-299.
21. Davies KJ (1999): The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 48:41-47.
22. de Bruijn WC, Boeve ER, van Run PR, van Miert PP, de Water R, Romijn JC, Verkoelen CF, Cao LC, Schroder FH (1995): Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation? Scanning Microsc 9:103-114.
23. de Water R, Noordermeer C, van der Kwast TH, Nizze H, Boeve ER, Kok DJ, Schroder FH (1999): Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis 33:761-771.
24. de Water R, Noordermeer C, Houtsmuller AB, Nigg AL, Stijnen T, Schroder FH, Kok DJ (2000): Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium. Am J Kidney Dis 36:615-625.
25. Denhardt DT, Giachelli CM, Rittling SR (2001): Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 41:723-749.
26. Dennis EA (1997): The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci 22:1-2.
27. Di Tommaso L, Tolomelli B, Mezzini R, Marchetti M, Cenacchi G, Foschini MP, Mancini AM (2002): Renal calcium phosphate and oxalate deposition in prolonged vitamin B6 deficiency: studies on a rat model of urolithiasis. BJU Int 89:571-575.
28. Ebisuno S, Nishihata M, Inagaki T, Umehara M, Kohjimoto Y (1999): Bikunin prevents adhesion of calcium oxalate crystal to renal tubular cells in human urine. J Am Soc Nephrol 10 (Suppl 14):S436-440.
29. Eguchi Y, Inoue M, Iida S, Matsuoka K, Noda S (2002): Heparan sulfate (HS)/heparan sulfate proteoglycan (HSPG) and bikunin are up-regulated during calcium oxalate nephrolithiasis in rat kidney. Kurume Med J 49:99-107.
30. Finlayson B, Reid F (1978): The expectation of free and fixed particles in urinary stone disease. Invest Urol 15:442-448.
31. Fraser JD, Price PA (1988): Lung, heart, and kidney express high levels of mRNA for the vitamin K-dependent matrix Gla protein. Implications for the possible functions of matrix Gla protein and for the tissue distribution of the gamma-carboxylase. J Biol Chem 263: 11033-11036.
32. Fries E, Blom AM (2000): Bikunin - not just a plasma proteinase inhibitor. Int J Biochem Cell Biol 32:125-137.
33. Gambaro G, Bordoni A, Hrelia S, Bordin L, Biagi P, Semplicini A, Clari G, Manzato E, Baggio B (2000): Dietary manipulation of delta-6-desaturase modifies phospholipid arachidonic acid levels and the urinary excretion of calcium and oxalate in the rat: insight in calcium lithogenesis. J Lab Clin Med 135:89-95.
34. Gokhale JA, Glenton PA, Khan SR (2001): Characterization of Tamm-Horsfall protein in a rat nephrolithiasis model. J Urol 166:1492-1497.
35. Goodman HO, Brommage R, Assimos DG, Holmes RP (1997): Genes in idiopathic calcium oxalate stone disease. World J Urol 15:186-194.
36. Gunther W, Piwon N, Jentsch TJ (2003): The ClC-5 chloride channel knock-out mouse - an animal model for Dent's disease. Pflugers Arch 445:456-462.
37. Hackett RL, Shevock PN, Khan SR (1994): Madin-Darby canine kidney cells are injured by exposure to oxalate and to calcium oxalate crystals. Urol Res 22:197-204.
38. Hammes MS, Lieske JC, Pawar S, Spargo BH, Toback FG (1995): Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells. Kidney Int 48:501-509.
39. Hashizume T, Kitatani K, Kageura T, Hayama M, Akiba S, Sato T (1999): Ceramide enhances susceptibility of membrane phospholipids to phospholipase A2 through modification of lipid organization in platelet membranes. Biol Pharm Bull 22:1275-1278.
40. Hsieh N, Shih CH, Chen HY, Wu MC, Chen WC, Li CW (2003): Effects of Tamm-Horsfall protein on the protection of MCDK cells from oxalate induced free radical injury. Urol Res 31:10-16.
41. Huang HS, Ma MC, Chen J, Chen CF (2002): Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Urol 167:2584-2593.
42. Iida S, Miyajima J, Suzuki K, Matsuoka K, Inoue M, Noda S (1997): Expression of heparan sulfate proteoglycan mRNA in rat kidneys during calcium oxalate nephrolithiasis. Urol Res 25:361-364.
43. Iida S, Inoue M, Yoshii S, Yanagaki T, Chikama S, Shimada A, Matsuoka K, Noda S, Khan SR (1999a): Molecular detection of heparan sulfate proteoglycan mRNA in rat kidney during calcium oxalate nephrolithiasis. J Am Soc Nephrol 14(10 Suppl):S412-416.
44. Iida S, Peck AB, Byer KJ, Khan SR (1999b): Expression of bikunin mRNA in renal epithelial cells after oxalate exposure. J Urol 162:1480-1486.
45. Iida S, Peck AB, Johnson-Tardieu J, Moriyama M, Glenton PA, Byer KJ, Khan SR (1999c): Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis. J Am Soc Nephrol 10:986-996.
46. Jayadev S, Linardic CM, Hannun YA (1994): Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha. J Biol Chem 269:5757-5763.
47. Jiang XJ, Feng T, Chang LS, Kong XT, Wang G, Zhang ZW, Guo YL (1998): Expression ofosteopontin mRNA in normal and stone-forming rat kidney. Urol Res 26: 389-394.
48. Jonassen JA, Cooney R, Kennington L, Gravel K, Honeyman T, Scheid CR (1999): Oxalate-induced changes in the viability and growth of human renal epithelial cells. J Am Soc Nephrol 10(Suppl 14):S446-451.
49. Kamata H, Hirata H (1999): Redox regulation of cellular signalling. Cell Signal 11:1-14.
50. Katsuma S, Shiojima S, Hirasawa A, Takagaki K, Kaminishi Y, Koba M, Hagidai Y, Murai M, Ohgi T, Yano J, Tsujimoto G (2002): Global analysis of differentially expressed genes during progression of calcium oxalate nephrolithiasis. Biochem Biophys Res Commun 296:544-552.
51. Khan SR (1991): Pathogenesis of oxalate urolithiasis: lessons from experimental studies with rats. Am J Kidney Dis 17:398-401.
52. Khan SR, Shevock PN, Hackett RL (1992): Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. J Urol 147:226-230.
53. Khan, SR, Hackett RL (1993): Hyperoxaluria, enzymuria and nephrolithiasis. Contrib Nephrol 101:190-193.
54. Khan SR, Byer KJ, Thamilselvan S, Hackett RL, McCormack WT, Benson NA, Vaughn KL, Erdos GW (1999): Crystal-cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells. J Am Soc Nephrol 10(Suppl 14):S457-S463.
55. Khan SR, Johnson JM, Peck AB, Cornelius JG, Glenton PA (2002): Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis. J Urol 168:1173-1181.
56. Khand FD, Gordge MP, Robertson WG, Noronha-Dutra AA, Hothersall JS (2002): Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells. Free Radic Biol Med 32:1339-1350.
57. Kohjimoto Y, Kennington L, Scheid CR, Honeyman TW (1999): Role of phospholipase A2 in the cytotoxic effects of oxalate in cultured renal epithelial cells. Kidney Int 56:1432-1441.
58. Kohjimoto Y, Honeyman TW, Jonassen J, Gravel K, Kennington L, Scheid CR (2000): Phospholipase A2 mediates immediate early genes in cultured renal epithelial cells: possible role of lysophospholipid. Kidney Int 58:638-646.
59. Kohri K, Nomura S, Kitamura Y, Nagata T, Yoshioka K, Iguchi M, Yamate T, Umekawa T, Suzuki Y, Sinohara H, Kurita T (1993): Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268:15180-15184.
60. Kokot F, Dulawa J (2000): Tamm-Horsfall protein updated. Nephron 85:97-102.
61. Koul H, Ebisuno S, Renzulli L, Yanagawa M, Menon M, Scheid C (1994a): Polarized distribution of oxalate transport systems in LLC-PK1 cells, a line of renal epithelial cells. Am J Physiol 266:F266-274.
62. Koul H, Kennington L, Nair G, Honeyman T, Menon M, Scheid C (1994b): Oxalate-induced initiation of DNA synthesis in LLC-PK1 cells, a line of renal epithelial cells. Biochem Biophys Res Commun 205:1632-1637.
63. Koul H, Kennington L, Honeyman T, Jonassen J, Menon M, Scheid C (1996): Activation of c-myc gene mediates the mitogenic effects of oxalate in LLC-PK1 cells, a line of renal epithelial cells. Kidney Int 50:1525-1530.
64. Kumar S, Sigmon D, Miller T, Carpenter B, Khan S, Malhotra R, Scheid C, Menon M (1991): A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol 146:1384-1389.
65. Lieske JC, Walsh-Reitz MM, Toback FG (1992): Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol 262:F622-F630.
66. Lieske JC, Leonard R, Toback FG (1995): Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol 268:F604-F612.
67. Lieske JC, Leonard R, Swift H, Toback FG (1996): Adhesion of calcium oxalate monohydrate crystals to anionic sites on the surface of renal epithelial cells. Am J Physiol 270:F192-F199.
68. Lieske JC, Hammes MS, Hoyer JR, Toback FG (1997): Renal cell osteopontin production is stimulated by calcium oxalate monohydrate crystals. Kidney Int 51: 679-686.
69. Lieske JC, Toback FG, Deganello S (2001): Sialic acid-containing glycoproteins on renal cells determine nucleation of calcium oxalate dihydrate crystals. Kidney Int 60:1784-1791.
70. Loeffler M, Kroemer G (2000): The mitochondrion in cell death control: certainties and incognita. Exp Cell Res 256:19-26.
71. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G (1997): Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78-81.
72. Mandel N, Riese R (1991): Crystal-cell interactions: crystal binding to rat renal papillary tip collecting duct cells in culture. Am J Kidney Dis 17:402-406.
73. Marengo SR, Chen DH, Kaung HL, Resnick MI, Yang L (2002): Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis. J Urol 167:2192-2197.
74. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, Hughes J (2002): Osteopontin - a molecule for all seasons. QJ Med 95:3-13.
75. Médétognon-Benissan J, Tardivel S, Hennequin C, Daudon M, Drüeke T, Lacour B (1999): Inhibitory effect of bikunin on calcium oxalate crystallization in vitro and urinary bikunin decrease in renal stone formers. Urol Res 27:69-75.
76. Miller C, Kennington L, Cooney R, Honeyman T, Kohjimoto Y, Cao LC, Pullman J, Jonassen J, Scheid CR (2000): Oxalate toxicity in renal epithelial cells: Characteristics of apoptosis and necrosis. Toxicol Appl Pharm 162:132-141.
77. Moriyama MT, Glenton PA, Khan SR (2001): Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats. J Urol 165:1687-1692.
78. Muthukumar A, Selvam R (1997): Renal injury mediated calcium oxalate nephrolithiasis: role of lipid peroxidation. Renal Fail 19:401-408.
79. Muthukumar A, Selvam R (1998): Role of glutathione on renal mitochondrial status in hyperoxaluria. Mol Cell Biochem 185:77-84.
80. Pak CY (1998): Kidney stones. Lancet 351:1797-1801.
81. Pillay SN, Asplin JR, Coe FL (1998): Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization. Am J Physiol 275:F255-F261.
82. Ravichandran V, Selvam R (1990): Increased lipid peroxidation in kidney of vitamin B-6 deficient rats. Biochem Int 21:599-605.
83. Riese RJ, Mandel NS, Wiessner JH, Mandel GS, Becker CG, Kleinman JG (1992): Cell polarity and calcium oxalate crystal adherence to cultured collecting duct cells. Am J Physiol 262:F177-184.
84. Riese RJ, Riese JW, Kleinman JG, Wiessner JH, Mandel GS, Mandel NS (1988): Specificity in calcium oxalate adherence to papillary epithelial cells in cultures. Am J Physiol 255: F1025-1032.
85. Riboni L, Viani P, Bassi R, Prinetti A, Tettamanti G (1997): The role of sphingolipids in the process of signal transduction. Prog Lipid Res 36:153-195.
86. Sambrano GR, Steinberg D (1995): Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: Role of membrane phosphatidylserine. Proc Natl Acad Sci USA 92:1396-1400.
87. Sapirstein A, Spech RA, Witzgall R, Bonventre JV (1996): Cytosolic phospholipase A2 (PLA2), but not secretory PLA2, potentiates hydrogen peroxide cytotoxicity in kidney epithelial cells. J Biol Chem 271:21505-21513.
88. Sayer JA, Simmons NL (2002): Urinary stone formation: Dent's disease moves understanding forward. Exp Nephrol 10:176-181.
89. Scheid CR, Koul H, Kennington L, Hill WA, Luber-Narod J, Jonassen J, Honeyman T, Menon M (1995): Oxalate-induced damage to renal tubular cells. A review. Scanning Microsc 9:1097-1107.
90. Scheid, CR, Jonassen J, Woodland R, Schmidt M, Koul H, Menon M (1996a): Overexpression of bcl-2 protects against oxalate toxicity in LLC-PK1 cells. In Pak CY, Resnick MI, Preminger GM (eds):" Urolithiasis 1996," Proc Eighth Int Symp on Urolithiasis. Dallas: Millet The Printer, Inc., 70-71.
91. Scheid CR, Koul H, Hill WA, Luber-Narod J, Jonassen J, Honeyman T, Kennington L, Kohli R, Hodapp J, Ayvazian P, Menon M (1996b): Oxalate toxicity in LLC-PK1 cells, a line of renal epithelial cells. J Urol 155:1112-1116.
92. Scheid C, Koul H, Hill WA, Luber-Narod J, Kennington L, Honeyman T, Jonassen J, Menon M (1996c): Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kidney Int 49:413-419.
93. Scheid C, Honeyman T, Kohjimoto Y, Cao LC, Jonassen J (2000): Oxalate-induced changes in renal epithelial cell function: role in stone disease. Mol Urol 4:371-382.
94. Scheinman SJ (1999): Nephrolithiasis. Semin Nephrol 19:381-388.
95. Schnellman RG, Yang X, Carrick JB (1994): Arachidonic acid release in renal proximal tubule cell injuries and death. J Biochem Toxicol 9:211-217.
96. Selvam R, Kurien TB (1987): Induction of lipid peroxidation by oxalate in experimental rat urolithiasis. J BioSci 12:367-373.
97. Selvam R, Bijikurien T (1992): Effect of citrate feeding on free radical induced changes in experimental urolithiasis. Indian J Exp Biol 30:705-710.
98. Selvam R, Devaraj S (1996): Oxalate binding to rat kidney mitochondria: induction by oxidized glutathione. Ind J Biochem Biophys 33:62-65.
99. Selvam R (2002): Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 30:35-47.
100. Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG, Hoyer JR (1992): Inhibition of calcium oxalate growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426-430.
101. Silkensen JR, Schwochau GB, Rosenberg ME (1994): The role of clusterin in tissue injury. Biochem Cell Biol 72:483-488.
102. Speer MY, McKee MD, Guldberg RE, Liaw L, Yang HY, Tung E, Karsenty G, Giachelli CM (2002): Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 196:1047-1055.
103. Strzelecki T, Menon M (1986): The uptake of oxalate by rat liver and kidney mitochondria. J Biol Chem. 261: 12197-12201.
104. Strzelecki T, McGraw BR, Scheid CR, Menon M (1989): Effect of oxalate on function of kidney mitochondria. J Urol 141:423-427.
105. Sumathi R, Jayanthi S, Kalpanadevi V, Varalakshmi P (1993): Effect of DL alpha-lipoic acid on tissue lipid peroxidation and antioxidant systems in normal and glycollate treated rats. Pharmacol Res 27:309-318.
106. Tawada T, Fujita K, Sakakura T, Shibutani T, Nagata T, Iguchi M, Kohri K (1999): Distribution of osteopontin and calprotectin as matrix protein in calcium-containing stone. Urol Res 27:238-242.
107. Thakker RV (1999): Chloride channels in renal disease. Adv Nephrol Necker Hosp 29:289-298.
108. Thamilselvan S, Hackett RL, Khan SR (1997): Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059-1063.
109. Thamilselvan S, Khan SR (1998): Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies. J Nephrol 11 (Suppl 1):66-69.
110. Thamilselvan S, Byer KJ, Hackett RL, Khan SR (2000): Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 164: 224-229.
111. Thamilselvan S, Khan SR, Menon M (2003): Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3-9.
112. Thannickal VJ, Fanburg BL (2000): Reactive oxygen species in cell signaling. Am J Physiol 279: L1005-L1028.
113. Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F (2001): Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol 166:275-280.
114. Toblli JE, Stella I, de Cavanagh E, Angerosa M, Inserra F, Ferder L (1999): Enalapril prevents tubulointerstitial lesions by hyperoxaluria. Hypertension 33:225-231.
115. Toblli JE, Ferder L, Stella I, De Cavanaugh EM, Angerosa M, Inserra F (2002): Effects of angiotensin II sub-type 1 receptor blockade by losartan on rubulointerstitial lesions caused by hyperoxaluria. J Urol 168:1550-1555.
116. Umekawa T, Kohri K, Kurita R, Hirota S, Nomura S, Kitamura Y (1995): Expression of osteopontin messenger RNA in the rat kidney on experimental model of renal stone disease. Biochem Mol Biol Int 35: 223-230.
117. Umekawa T, Iguchi M, Konya E, Yamate T, Amasaki N, Kurita T (1999): Localization and inhibitory activity of alpha(2)HS-glycoprotein in the kidney. Urol Res 27:315-318.
118. Umekawa T, Chegini N, Khan SR (2002): Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int 61:105-112.
119. Umekawa T, Chegini N, Khan SR (2003): Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 18:664-669.
120. Verkoelen CF, van der Boom BG, Houtsmuller AB, Schroder FH, Romijn JC (1998): Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture. Am J Physiol 274:F958-965.
121. Verkoelen CF, van der Boom BG, Kok DJ, Romijn JC (2000a): Sialic acid and crystal binding. Kidney Int 57:1072-1082.
122. Verkoelen CF, Van Der Boom BG, Romijn JC (2000b): Identification of hyaluronan as a crystal-binding molecule at the surface of migrating and proliferating MDCK cells. Kidney Int 58:1045-1054.
123. Wesson JA, Johnson RJ, Mazzali M, Beshensky AM, Stietz S, Giachelli C, Liaw L, Alpers CE, Couser WG, Kleinman JG, Hughes J (2003): Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 14:139-147.
124. Wiessner JH, Hasegawa AT, Hung LY, Mandel GS, Mandel NS (2001): Mechanisms of calcium oxalate crystal attachment to injured renal collecting duct cells. Kidney Int 59:637-644.
125. Worcester EM (1996): Inhibitors of stone formation. Semin Nephrol 16:474-486.
126. Worcester EM, Beshensky AM (1995): Osteopontin inhibits nucleation of calcium oxalate crystals. Ann N Y Acad Sci 760:375-377.
127. Xie, Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F (2001): Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 60:1645-1657.
128. Yasui T, Fujita K, Sasaki S, Sato M, Sugimoto M, Hirota S, Kitamura Y, Nomura S, Kohri K (1999): Expression of bone matrix proteins in urolithiasis model rats. Urol Res 27:255-261.
129. Yasui T, Sato M, Fujita K, Ito Y, Nomura S, Kohri K (2001a): Effects of allopurinol on renal stone formation and osteopontin expression in a rat urolithiasis model. Nephron 87:170-176.
130. Yasui T, Sato M, Fujita K, Tozawa K, Nomura S, Kohri K (2001b): Effects of citrate on renal stone formation and osteopontin expression in a rat urolithiasis model. Urol Res 29:50-56.